Sign in to continue:

Friday, March 13th, 2026

Chemours Completes $700 Million Private Offering of 7.875% Senior Unsecured Notes Due 2034 to Redeem 2027 and 2028 Notes

Chemours Company Completes \$700 Million Private Bond Offering, Announces Planned Redemptions of Existing Notes

Wilmington, Del., March 12, 2026 — The Chemours Company (NYSE: CC), a global leader in industrial and specialty chemicals, has announced the successful completion of a significant private offering. The company raised \$700 million in aggregate principal through the issuance of 7.875% senior unsecured notes due 2034. These notes are guaranteed by one of Chemours’ subsidiaries and were offered exclusively to qualified institutional buyers pursuant to Rule 144A and to non-U.S. persons under Regulation S, both exemptions under the Securities Act of 1933.

Key Highlights for Investors

  • Bond Offering Details: Chemours issued \$700 million in senior unsecured notes with a fixed interest rate of 7.875% and a maturity date in 2034. The notes are not registered under the Securities Act and are only available to select institutional and international investors.
  • Use of Proceeds: The net proceeds from this offering, combined with cash on hand, were used to fund the redemption of \$188 million of its 5.750% senior notes due 2028. The aggregate redemption price was approximately \$189.8 million, plus accrued and unpaid interest. The remaining proceeds are expected to be used to redeem the outstanding 5.375% senior notes due 2027, with an aggregate redemption price estimated at \$500.3 million (based on a treasury rate of 3.56%), plus accrued and unpaid interest up to the date of redemption.
  • Impact on Capital Structure: These transactions mark a major refinancing move for Chemours, replacing older, lower-rate debt with new, higher-rate obligations. Investors should note the increase in interest expense going forward, but also the potential improvement in liquidity and debt maturity profile.
  • No Registration, Limited Offer: The new notes and their guarantees will not be registered under U.S. or state securities laws, and cannot be offered or sold publicly unless registered or exempted. This restricts trading and liquidity for these instruments.
  • No Offer to Purchase Existing Notes: The press release specifically states this is not an offer to purchase or solicitation of sale for the existing 2027 or 2028 notes. Any redemption notices will be sent only to holders according to the relevant indentures.

Business Overview & Market Presence

Chemours operates across three business segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. Its products are marketed under leading brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. The company is headquartered in Wilmington, Delaware, employs approximately 5,700 people, runs 28 manufacturing sites, and serves about 2,400 customers in 110 countries.

Forward-Looking Statements: Risks and Opportunities

The company’s statements regarding its intended use of proceeds and planned redemptions are forward-looking and subject to risks and uncertainties. Factors impacting the outcome include the actual execution of redemptions, changes in market conditions, and other risks detailed in Chemours’ filings with the SEC, notably its Annual Report for the year ended December 31, 2025.

Potential Share Price Impact

  • Debt Refinancing Moves: Investors should closely monitor Chemours’ refinancing activities. While the company is improving its debt maturity profile and retiring older obligations, the new notes carry a higher interest rate, potentially impacting future earnings and cash flows.
  • Redemption Plans: The planned redemption of the 2027 and 2028 notes could affect liquidity and capital allocation strategies, and may be interpreted as a sign of financial strength or shifting risk profile.
  • Forward-Looking Uncertainties: As with all forward-looking statements, execution risk remains. Investors should review Chemours’ SEC filings for comprehensive risk factors.

Investor Contacts

Investors: Brandon Ontjes, Vice President, Head of Strategy & Investor Relations: +1.302.773.3309, [email protected]
Media: Cassie Olszewski, Media Relations & Reputation Leader: +1.302.219.7140, [email protected]


Disclaimer: This article is intended for informational purposes only and does not constitute investment advice, an offer to buy or sell securities, or a solicitation. Investors should review Chemours’ filings with the SEC and consult their financial advisors before making any investment decisions. The information herein is based on the company’s press release and may be subject to change or revision without notice.

View Chemours Co Historical chart here



Guardian Pharmacy Services, Inc. 2025 Annual Report: Business Overview, Growth Strategy, and Competitive Advantages

Overview Guardian Pharmacy Services, Inc. (“Guardian” or ...

Invitation Homes Inc. March 2026 Investor Presentation and Regulation FD Disclosure Highlights

Invitation Homes Inc. 8-K Filing: Key Updates and Investor I...

   Ad